Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
Endoscopy · 01.12.2023 · 55 (12) · 1061-1069
DOI: 10.1055/a-2136-6564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.12.2023. Verfasst von Hilliene J van de Schootbrugge-Vandermeer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negative colonoscopy in FIT-positive individuals.
Methods
In this cross-sectional cohort study, data were extracted from the Dutch national screening information system. Participants with a positive FIT followed by a negative colonoscopy between 2014 and 2018 were included. A negative colonoscopy was defined as a colonoscopy during which no more than one nonvillous, nonproximal adenoma < 10 mm or serrated polyp < 10 mm was found. The main outcome was interval post-colonoscopy CRC (iPCCRC) risk. iPCCRC risk was reviewed against the risk of interval CRC after a negative FIT (FIT IC) with a 2-year screening interval.
Results
35 052 FIT-positive participants had a negative colonoscopy and 24 iPCCRCs were diagnosed, resulting in an iPCCRC risk of 6.85 (95 %CI 4.60–10.19) per 10 000 individuals after a median follow-up of 1.4 years. After 2.5 years of follow-up, age-adjusted iPCCRC risk was approximately equal to FIT IC risk at 2 years.
Conclusion
Risk of iPCCRC within a FIT-based CRC screening program was low during the first years after colonos-copy but, after 2.5 years, was the same as the risk in FIT-negative individuals at 2 years, when they are reinvited for screening. Colonoscopy quality may therefore require further improvement and FIT screening interval may need to be reduced after negative colonoscopy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
- Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
- Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
- Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
ORCID-Profile: Hilliene J van de Schootbrugge-Vandermeer, Arthur I Kooyker, Esther Toes-Zoutendijk, Evelien Dekker, Manon C W Spaander
Zitieren
APA
van de Schootbrugge-Vandermeer, H. J., Kooyker, A. I., Wisse, P. H. A., Nagtegaal, I. D., Geuzinge, H. A., Toes-Zoutendijk, E., de Jonge, L., Breekveldt, E. C. H., van Vuuren, A. J., van Kemenade, F. J., Ramakers, C. R. B., Dekker, E., Lansdorp-Vogelaar, I., Spaander, M. C. W., & van Leerdam, M. E. (2023). Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program. Endoscopy, 55(12), 1061-1069. https://doi.org/10.1055/a-2136-6564
Vancouver
van de Schootbrugge-Vandermeer HJ, Kooyker AI, Wisse PHA, Nagtegaal ID, Geuzinge HA, Toes-Zoutendijk E, et al. Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program. Endoscopy. 2023;55(12):1061-1069. doi:10.1055/a-2136-6564
BibTeX
@article{vandeSchootbruggeVandermeer2023,
author = {van de Schootbrugge-Vandermeer, Hilliene J and Kooyker, Arthur I and Wisse, Pieter H A and Nagtegaal, Iris D and Geuzinge, Hiltje A and Toes-Zoutendijk, Esther and de Jonge, Lucie and Breekveldt, Emilie C H and van Vuuren, Anneke J and van Kemenade, Folkert J and Ramakers, Christian R B and Dekker, Evelien and Lansdorp-Vogelaar, Iris and Spaander, Manon C W and van Leerdam, Monique E},
title = {Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program},
journal = {Endoscopy},
year = {2023},
volume = {55},
number = {12},
pages = {1061--1069},
doi = {10.1055/a-2136-6564}
}
EUVIMED